Belimumab for systemic lupus erythematosus

N Engl J Med. 2013 Apr 18;368(16):1528-35. doi: 10.1056/NEJMct1207259.
No abstract available

Publication types

  • Review

MeSH terms

  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Female
  • Humans
  • Lupus Erythematosus, Systemic / drug therapy*
  • Young Adult

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • belimumab